MCID: PRT019
MIFTS: 40

Protein-Losing Enteropathy

Categories: Gastrointestinal diseases

Aliases & Classifications for Protein-Losing Enteropathy

MalaCards integrated aliases for Protein-Losing Enteropathy:

Name: Protein-Losing Enteropathy 12 14
Protein-Losing Enteropathies 51 41 69
Enteropathy, Protein-Losing 28
Enteropathy, Exudative 12
Exudative Enteropathy 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10611
MeSH 41 D011504
SNOMED-CT 64 22542007 66972006
UMLS 69 C0033680

Summaries for Protein-Losing Enteropathy

MalaCards based summary : Protein-Losing Enteropathy, also known as protein-losing enteropathies, is related to congenital disorder of glycosylation, type ib and constrictive pericarditis. An important gene associated with Protein-Losing Enteropathy is CD55 (CD55 Molecule (Cromer Blood Group)), and among its related pathways/superpathways is Transport to the Golgi and subsequent modification. The drugs Fibrinolytic Agents and Plasminogen have been mentioned in the context of this disorder. Affiliated tissues include heart, small intestine and liver.

Wikipedia : 72 Protein losing enteropathy refers to any condition of the gastrointestinal tract (e.g. damage to the gut... more...

Related Diseases for Protein-Losing Enteropathy

Diseases related to Protein-Losing Enteropathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 246)
# Related Disease Score Top Affiliating Genes
1 congenital disorder of glycosylation, type ib 33.7 MPI SERPINA1
2 constrictive pericarditis 30.9 ALB SERPINA1
3 polyposis, skin pigmentation, alopecia, and fingernail changes 30.6 ALB SERPINA1
4 diarrhea 30.2 ALB CD79A DGAT1
5 protein-energy malnutrition 30.2 ALB CD79A
6 congenital disorder of glycosylation, type in 30.2 ALG6 MPI
7 hennekam syndrome 30.1 ALB SERPINA1
8 intestinal disease 30.1 ALB CD79A
9 yellow nail syndrome 30.0 ALB CD79A
10 chronic graft versus host disease 30.0 ALB CD79A
11 bronchitis 29.9 ALB CD79A SERPINA1
12 schistosomiasis 29.8 ALB CD79A
13 acquired immunodeficiency syndrome 29.4 ALB CD79A
14 complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy 12.7
15 congenital diarrhea 7 with exudative enteropathy 11.8
16 lymphangiectasis 11.4
17 primary intestinal lymphangiectasia 11.4
18 diarrhea 7 11.3
19 congenital disorder of glycosylation, type ic 11.1
20 lupus erythematosus 10.7
21 systemic lupus erythematosus 10.7
22 lymphoma 10.4
23 colitis 10.4
24 pericarditis 10.4
25 heart disease 10.4
26 gastroenteritis 10.4
27 eosinophilic gastroenteritis 10.4
28 amyloidosis 10.4
29 hepatitis 10.3
30 collagenous colitis 10.3
31 thrombosis 10.3
32 fibrosis of extraocular muscles, congenital, 1 10.3
33 crohn's disease 10.3
34 connective tissue disease 10.3
35 purpura 10.2
36 hepatic tuberculosis 10.2 ALB SERPINA1
37 transient arthritis 10.2 ALB SERPINA1
38 endodermal sinus tumor 10.2 ALB SERPINA1
39 cataract 32, multiple types 10.2
40 rheumatoid arthritis 10.2
41 neuroblastoma 10.2
42 arthritis 10.2
43 ulcerative colitis 10.2
44 sarcoma 10.2
45 dermatitis 10.2
46 lymphangiomatosis 10.2
47 cap polyposis 10.2
48 plastic bronchitis 10.2
49 cork-handlers' disease 10.2 ALB CD79A
50 ostertagiasis 10.2 ALB CD79A

Graphical network of the top 20 diseases related to Protein-Losing Enteropathy:



Diseases related to Protein-Losing Enteropathy

Symptoms & Phenotypes for Protein-Losing Enteropathy

Drugs & Therapeutics for Protein-Losing Enteropathy

Drugs for Protein-Losing Enteropathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 17)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Fibrinolytic Agents Phase 2
2 Plasminogen Phase 2
3 Tissue Plasminogen Activator Phase 2
4
Heparin Approved, Investigational Phase 1 9005-49-6 46507594 772
5 calcium heparin Phase 1
6
Dopamine Approved 51-61-6, 62-31-7 681
7
Substance P Investigational 33507-63-0 44359816
8 Gastrointestinal Agents
9 neurokinin A
10 Neuroprotective Agents
11 Protective Agents
12 Vasoactive intestinal peptide 40077-57-4
13 Vasodilator Agents
14 Autonomic Agents
15 Dopamine Agents
16 Neurotransmitter Agents
17 Peripheral Nervous System Agents

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis Recruiting NCT02315898 Phase 2 Treatment-inhaled tPA
2 Pilot/Ph I Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery Terminated NCT01161641 Phase 1 ODSH at 0.125 mg/kg/h;ODSH at 0.375 mg/kg/h;ODSH at 0.250 mg/kg/h
3 Plastic Bronchitis and Protein Losing Enteropathy in Children With Single Ventricle Physiology Completed NCT01563757
4 International Lymphatic Disease and Lymphedema Registry Recruiting NCT01336790
5 Lymphatic Function in Patients With a Fontan-Kreutzer Circulation Active, not recruiting NCT03379805
6 Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing Enteropathy Enrolling by invitation NCT03322345

Search NIH Clinical Center for Protein-Losing Enteropathy

Cochrane evidence based reviews: protein-losing enteropathies

Genetic Tests for Protein-Losing Enteropathy

Genetic tests related to Protein-Losing Enteropathy:

# Genetic test Affiliating Genes
1 Enteropathy, Protein-Losing 28 CD55

Anatomical Context for Protein-Losing Enteropathy

MalaCards organs/tissues related to Protein-Losing Enteropathy:

38
Heart, Small Intestine, Liver, Colon, Bone, Testes, Breast

Publications for Protein-Losing Enteropathy

Articles related to Protein-Losing Enteropathy:

(show top 50) (show all 594)
# Title Authors Year
1
Identical twins with XLA requiring differing amounts of 20% subcutaneous immunoglobulin secondary to protein-losing enteropathy. ( 29339123 )
2018
2
Protein Losing Enteropathy in Hennekam Syndrome. ( 29327272 )
2018
3
Echocardiographic characteristics in Fontan patients before the onset of protein-losing enteropathy or plastic bronchitis. ( 29082544 )
2018
4
Undetectable antimicrobial plasma concentrations in an HIV-positive patient with protein-losing enteropathy and chylothorax during Mycobacterium genavense and Leishmania abdominal infections. ( 29077870 )
2018
5
Evaluation by MR Enterocolonography of Lansoprazole-induced Collagenous Colitis Accompanied with Protein-losing Enteropathy. ( 29033425 )
2018
6
Protein-losing Enteropathy Caused by Spontaneous Reduction of Intussusception with Meckel's Diverticulum. ( 28413865 )
2017
7
CD55 Deficiency and Protein-Losing Enteropathy. ( 29022673 )
2017
8
A case of protein-losing enteropathy caused by sclerosing mesenteritis diagnosed with capsule endoscopy and double-balloon endoscopy. ( 28664384 )
2017
9
CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis. ( 28657829 )
2017
10
Loss of CD55 in Eculizumab-Responsive Protein-Losing Enteropathy. ( 28657861 )
2017
11
Once More Unto the Breach: A New Treatment Paradigm for Protein-Losing Enteropathy. ( 28619194 )
2017
12
Protein-losing enteropathy resolved after ventral abdominal hernia repair. ( 28743538 )
2017
13
Nonsteroidal anti-inflammatory drug-induced protein-losing enteropathy: a great masquerade of Crohn's disease. ( 28554654 )
2017
14
Disseminated Mycobacterium avium intracellulare leading to protein-losing enteropathy in an elderly man with idiopathic CD4 lymphocytopenia. ( 28958380 )
2017
15
Cytomegalovirus-associated protein-losing enteropathy in a healthy man. ( 28802763 )
2017
16
Congenital Diarrhea from DGAT1 Mutation Leading to Electrolyte Derangements, Protein-Losing Enteropathy, and Rickets. ( 28937539 )
2017
17
Lupus protein-losing enteropathy patient with protein C and protein S deficiency-induced thrombosis: A case report with review of the literature. ( 28375198 )
2017
18
Investigation of the Influence of Protein-Losing Enteropathy on Monoclonal Antibody Pharmacokinetics in Mice. ( 28849396 )
2017
19
Bilateral Serous Macular Elevation Associated with Lupus Protein-losing Enteropathy. ( 28540024 )
2017
20
Protein-Losing Enteropathy as a Complication of the Ketogenic Diet. ( 28541008 )
2017
21
Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states. ( 28761367 )
2017
22
Reply: The Need to Define Treatment Goals for Protein-Losing Enteropathy in Fontan Care and Research. ( 29145958 )
2017
23
Protein-losing Enteropathy Caused by Intestinal or Colonic Lymphangiectasia Complicated by Sporadic Lymphangioleiomyomatosis: A Report of Two Cases. ( 28420844 )
2017
24
The Need to Define Treatment Goals for Protein-Losing Enteropathy in Fontan Care and Research. ( 29145957 )
2017
25
CD55 Deficiency and Protein-Losing Enteropathy. ( 29020581 )
2017
26
CD55 Deficiency and Protein-Losing Enteropathy. ( 29020582 )
2017
27
An Early Glenn Operation May be Associated with the Later Occurrence of Protein-Losing Enteropathy in Fontan Patients : Association of Early Glenn and Failing Fontan. ( 28534240 )
2017
28
Localized gastrointestinal amyloidosis presenting with protein-losing enteropathy and massive hemorrhage. ( 29106288 )
2017
29
Multiple small intestinal ulcers associated with protein-losing enteropathy secondary to cholesterol crystal embolism:a case report. ( 28781354 )
2017
30
Gastrointestinal haemorrhage due to lymphangiectasia caused by protein-losing enteropathy in the Fontan circulation. ( 28651669 )
2017
31
Selenium status and fungi in the protein-losing enteropathy of persistent diarrhea. ( 28625042 )
2017
32
Acute onset collagenous colitis associated with protein-losing enteropathy. ( 29264009 )
2017
33
Somatic PTPN11 Mutation in a Child With Neuroblastoma and Protein Losing Enteropathy. ( 29189514 )
2017
34
Protein-Losing Enteropathy in Patients With Congenital Heart Disease. ( 28619193 )
2017
35
Massive Mesenteric Lymphadenopathy Causing Protein-losing Enteropathy in Gaucher Disease. ( 28060125 )
2017
36
Protein-losing enteropathy in a patient on peritoneal dialysis. ( 28434705 )
2017
37
Constrictive Pericarditis and Protein-Losing Enteropathy: Is Extremely Severe Hypoalbuminemia Reversible by Pericardiectomy? ( 27864304 )
2016
38
Successful therapy for protein-losing enteropathy caused by chronic neuronopathic Gaucher disease. ( 27014572 )
2016
39
Protein Losing Enteropathy After Cardiac Transplantation Successfully Treated by Stent Implantation. ( 27549730 )
2016
40
Congenital protein losing enteropathy: an inborn error of lipid metabolism due to DGAT1 mutations. ( 26883093 )
2016
41
Retrospective evaluation of the administration of 25% human albumin to dogs with protein-losing enteropathy: 21 cases (2003-2013). ( 27159733 )
2016
42
Protein-losing enteropathy in camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome. ( 27224999 )
2016
43
Protein-losing enteropathy and erythema caused by egg allergy in a breast-fed infant. ( 26818703 )
2016
44
Thromboembolism in Dogs with Protein-Losing Enteropathy with Non-Neoplastic Chronic Small Intestinal Disease. ( 27841681 )
2016
45
Hypothyroidism and protein-losing enteropathy: A case report. ( 26705734 )
2016
46
Neonatal diabetes and protein losing enteropathy: a case report. ( 27098067 )
2016
47
Marginal Zone Lymphoma Complicated by Protein Losing Enteropathy. ( 27891267 )
2016
48
Towards a proposal for a universal diagnostic definition of protein-losing enteropathy in Fontan patients: a systematic review. ( 27033590 )
2016
49
Protein-losing enteropathy with entestinal lymphangiectasia in skeletal dysplasia with Lys650Met mutation. ( 27214123 )
2016
50
Hypoadrenocorticism mimicking protein-losing enteropathy in 4 dogs. ( 27429465 )
2016

Variations for Protein-Losing Enteropathy

ClinVar genetic disease variations for Protein-Losing Enteropathy:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 CD55 NM_001114752.1(CD55): c.43delC (p.Leu15Serfs) deletion Pathogenic rs1114167430 GRCh37 Chromosome 1, 207495153: 207495153
2 CD55 NM_000574.4(CD55): c.110delG (p.Gly37Alafs) deletion Pathogenic rs1135402915 GRCh37 Chromosome 1, 207495736: 207495736
3 CD55 NM_000574.4(CD55): c.149_150delAAinsCCTT (p.Glu50Alafs) indel Pathogenic rs1135402916 GRCh37 Chromosome 1, 207495775: 207495776
4 CD55 NM_000574.4(CD55): c.800G> C (p.Cys267Ser) single nucleotide variant Pathogenic rs1135402917 GRCh38 Chromosome 1, 207331243: 207331243
5 CD55 NM_000574.4(CD55): c.287-1G> A single nucleotide variant Pathogenic rs1135402918 GRCh37 Chromosome 1, 207497903: 207497903

Expression for Protein-Losing Enteropathy

Search GEO for disease gene expression data for Protein-Losing Enteropathy.

Pathways for Protein-Losing Enteropathy

GO Terms for Protein-Losing Enteropathy

Cellular components related to Protein-Losing Enteropathy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 endoplasmic reticulum-Golgi intermediate compartment membrane GO:0033116 9.16 CD55 SERPINA1
2 endoplasmic reticulum GO:0005783 9.02 ALB ALG6 DGAT1 FGFR3 SERPINA1
3 platelet alpha granule lumen GO:0031093 8.96 ALB SERPINA1

Sources for Protein-Losing Enteropathy

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....